Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Active surveillance of prostate cancer patients encouraged

Active surveillance is an effective way of monitoring patients with low-risk prostate cancer and is associated with a low risk for systemic progression, say researchers.

31 Dec 2012

Study reveals modest association between presence of tumor boards and types of cancer care

There is little association of multidisciplinary tumor boards with measures of use, quality, or survival, and measuring only the presence of tumor boards may not be adequate in determining their effects on cancer care, according to a study published December 28 in the Journal of the National Cancer Institute.

29 Dec 2012

Make palliative care available to Parkinson's patients

A modified version of the Edmonton Symptom Assessment System Scale is quick and effective at assessing patients with late-stage Parkinson's disease, and reveals that they have similar levels of symptoms as their peers with metastatic cancer, show study results from Canada.

28 Dec 2012

Study reveals decline in cancer screening rates

The rate of people who seek preventive cancer screenings has fallen over the last ten years in the United States with wide variations between white-collar and blue-collar workers, according to a University of Miami Miller School of Medicine study published on December 27 in the open-access journal Frontiers in Cancer Epidemiology.

27 Dec 2012

Survey reveals significant improvement in delivery of underused care

An analysis of nationally representative survey data found significant improvement in the delivery of underused care, but more limited changes in the reduction of inappropriate care in ambulatory health care settings between 1998 and 2009, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.

25 Dec 2012

MRI fused with ultrasound to strengthen prostate cancer diagnosis

Researchers have developed a technique that fuses magnetic resonance imaging with ultrasound to improve the detection and treatment of prostate cancer.

24 Dec 2012

Androgen deprivation therapies may have adverse effects in men with precancers

The use of androgen deprivation therapies to prevent precancerous prostate abnormalities developing into aggressive prostate cancer may have adverse effects in men with precancers with specific genetic alterations, according to data from a preclinical study recently published in Cancer Discovery, a journal of the American Association for Cancer Research.

21 Dec 2012

Researchers develop game-changing diagnostic and prognostic genetic tests for prostate cancer

Researchers at the Kimmel Cancer Center at Jefferson (KCC) have developed potentially game-changing diagnostic and prognostic genetic tests shown to better predict prostate cancer survival outcomes and distinguish clinically-relevant cancers.

21 Dec 2012

Dedicated palliative care consults improve outcomes

Data from a long-term care facility in the USA indicate that a dedicated palliative care consult service results in a more favorable course of treatment and clinical outcomes for residents.

19 Dec 2012

Numerous treatments exist for cancer-related fatigue, but few doctors recommend them to patients

Many people who have been through cancer and its treatment have trouble with their recovery because of severe, debilitating fatigue that can last for months or even years. But even though a variety of treatments exist for cancer-related fatigue, few doctors are recommending them to patients, according to a recent Mayo Clinic study appearing in Supportive Care in Cancer.

19 Dec 2012

PRSS3 enzyme linked to aggressive prostate cancer

Researchers at Mayo Clinic's campus in Florida have identified an enzyme specifically linked to aggressive prostate cancer, and have also developed a compound that inhibits the ability of this molecule to promote the metastatic spread of the cancer.

18 Dec 2012

Abiraterone improves outcomes for prostate cancer prior to chemo

Treatment with abiraterone acetate, an androgen biosynthesis inhibitor, may benefit patients with progressive metastatic castration-resistant prostate cancer who have not yet undergone chemotherapy, report researchers.

17 Dec 2012

New technique could help develop more-specific, cell-based immune therapies for cancer

A team led by Michel Sadelain, MD, PhD, Director of the Center for Cell Engineering at Memorial Sloan-Kettering Cancer Center, has shown for the first time the effectiveness of a new technique that could allow the development of more-specific, cell-based immune therapies for cancer.

17 Dec 2012

New diagnostic innovations could refine the way doctors detect prostate cancer

Despite the volume of prostate cancer tests and treatments, experts and their patients are continually challenged to predict the disease's course and apply the most appropriate treatment. Now, two new diagnostic innovations – the PCA3 urine test and a more targeted prostate biopsy technique - could refine the way doctors diagnose prostate cancer and, subsequently, the way patients elect to treat it.

15 Dec 2012

Bayer files radium-223 NDA with FDA for treatment of CRPC patients with bone metastases

Bayer HealthCare today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for radium Ra 223 dichloride (radium-223), an investigational compound for the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases.

15 Dec 2012

New finding likely to fuel cost-benefit debate over cancer care

A study published Thursday in the Journal of the National Cancer Institute concluded that proton-beam therapy provided no long-term benefit over traditional radiation despite far higher costs.

15 Dec 2012

Prostate cancer patients experience minimal relief from side effects following proton radiotherapy

Prostate cancer patients receiving the costly treatment known as proton radiotherapy experienced minimal relief from side effects such as incontinence and erectile dysfunction, compared to patients undergoing a standard radiation treatment called intensity modulated radiotherapy (IMRT), Yale School of Medicine researchers report in the Journal of the National Cancer Institute.

14 Dec 2012

Knocking out PKNP gene is the Achilles' heel of some cancers

Medical researchers at the University of Alberta have discovered that knocking out a particular "partner" gene is the Achilles' heel of some cancers.

14 Dec 2012

EZH2 protein enables advanced prostate cancers to spread without stimulation by male hormones

Scientists at Dana-Farber Cancer Institute have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones, which normally are needed to spur the cancer's growth. They say the finding could lead to a new treatment for prostate cancers that are no longer controlled by hormone-blocking drugs.

14 Dec 2012

Massage could ease distress of brain cancer

Massage therapy can significantly reduce distress levels in individuals with brain tumors, indicating its potential use to improve quality of life in this population, report US researchers.

13 Dec 2012

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Active surveillance of prostate cancer patients encouraged

Study reveals modest association between presence of tumor boards and types of cancer care

Make palliative care available to Parkinson's patients

Study reveals decline in cancer screening rates

Survey reveals significant improvement in delivery of underused care

MRI fused with ultrasound to strengthen prostate cancer diagnosis

Androgen deprivation therapies may have adverse effects in men with precancers

Researchers develop game-changing diagnostic and prognostic genetic tests for prostate cancer

Dedicated palliative care consults improve outcomes

Numerous treatments exist for cancer-related fatigue, but few doctors recommend them to patients

PRSS3 enzyme linked to aggressive prostate cancer

Abiraterone improves outcomes for prostate cancer prior to chemo

New technique could help develop more-specific, cell-based immune therapies for cancer

New diagnostic innovations could refine the way doctors detect prostate cancer

Bayer files radium-223 NDA with FDA for treatment of CRPC patients with bone metastases

New finding likely to fuel cost-benefit debate over cancer care

Prostate cancer patients experience minimal relief from side effects following proton radiotherapy

Knocking out PKNP gene is the Achilles' heel of some cancers

EZH2 protein enables advanced prostate cancers to spread without stimulation by male hormones

Massage could ease distress of brain cancer

What to know about prostate cancer eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in